Vestibular Modulation of Long-Term Potentiation and NMDA Receptor Expression in the Hippocampus.

CA1 E-S potentiation NMDA receptors bilateral vestibular loss dentate gyrus hippocampal long-term potentiation

Journal

Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914

Informations de publication

Date de publication:
2020
Historique:
received: 24 04 2020
accepted: 09 07 2020
entrez: 28 8 2020
pubmed: 28 8 2020
medline: 28 8 2020
Statut: epublish

Résumé

Loss of vestibular function is known to cause spatial memory deficits and hippocampal dysfunction, in terms of impaired place cell firing and abnormal theta rhythm. Based on these results, it has been of interest to determine whether vestibular loss also affects the development and maintenance of long-term potentiation (LTP) in the hippocampus. This article summarizes and critically reviews the studies of hippocampal LTP following a vestibular loss and its relationship to NMDA receptor expression, that have been published to date. Although the available

Identifiants

pubmed: 32848601
doi: 10.3389/fnmol.2020.00140
pmc: PMC7431471
doi:

Types de publication

Journal Article

Langues

eng

Pagination

140

Informations de copyright

Copyright © 2020 Smith, Truchet, Chaillan, Zheng and Besnard.

Références

Brain Res. 1993 May 14;611(1):7-17
pubmed: 8518951
Hippocampus. 2016 Dec;26(12):1509-1514
pubmed: 27569857
Brain Struct Funct. 2019 Mar;224(2):699-711
pubmed: 30470894
Behav Brain Res. 2012 Jun 15;232(1):174-82
pubmed: 22521836
J Physiol. 1982 Mar;324:249-62
pubmed: 7097600
Hippocampus. 2012 Apr;22(4):814-26
pubmed: 21538662
Neurobiol Aging. 1993 Jan-Feb;14(1):17-25
pubmed: 8450929
Brain Res. 1986 Mar 26;369(1-2):377-82
pubmed: 3516311
J Neurophysiol. 1994 Aug;72(2):605-11
pubmed: 7983522
Curr Opin Neurol. 2017 Feb;30(1):84-89
pubmed: 27845944
Eur Neuropsychopharmacol. 2014 Jul;24(7):1112-22
pubmed: 24582527
Hippocampus. 2003;13(8):873-8
pubmed: 14750650
J Neurosci. 2015 Apr 15;35(15):5926-34
pubmed: 25878265
Brain Struct Funct. 2017 Sep;222(7):3319-3332
pubmed: 28349227
Neuroscience. 2013 Jan 3;228:371-81
pubmed: 23103797
J Neurosci Methods. 2018 Jul 1;304:11-23
pubmed: 29660368
Neuron. 2017 Jan 18;93(2):281-290
pubmed: 28103477
Korean J Physiol Pharmacol. 2017 Jul;21(4):423-428
pubmed: 28706456
Ann Neurol. 2002 Sep;52(3):318-26
pubmed: 12205644
Nature. 1993 Jan 7;361(6407):31-9
pubmed: 8421494
Hippocampus. 2010 Apr;20(4):461-8
pubmed: 19533678
Brain Res. 1991 Oct 4;561(1):27-34
pubmed: 1797347
Hippocampus. 2012 May;22(5):1176-87
pubmed: 21748822
Front Integr Neurosci. 2014 Jul 23;8:59
pubmed: 25100954
J Neurosci. 2003 Jul 23;23(16):6490-8
pubmed: 12878690
Neuron. 2000 Apr;26(1):197-205
pubmed: 10798404
Hippocampus. 2002;12(3):291-303
pubmed: 12099481
J Neurophysiol. 2006 Jul;96(1):4-14
pubmed: 16772515
Nat Neurosci. 2017 Oct 26;20(11):1465-1473
pubmed: 29073639
Neuroreport. 2000 May 15;11(7):1443-7
pubmed: 10841354
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8874-9
pubmed: 11438685
Proc Natl Acad Sci U S A. 2019 May 14;116(20):10122-10129
pubmed: 31028140
Neuroscience. 2003;117(4):965-70
pubmed: 12654348
Brain Res Bull. 1997;43(5):447-55
pubmed: 9250618
Hippocampus. 2012 Apr;22(4):914-25
pubmed: 21542057
Front Integr Neurosci. 2015 Nov 10;9:55
pubmed: 26617498
Neuropharmacology. 1999 Nov;38(11):1755-66
pubmed: 10587091
Front Integr Neurosci. 2014 Jun 05;8:38
pubmed: 24926239
Neurosci Lett. 2018 Sep 14;683:43-47
pubmed: 29936267
Physiol Rev. 2004 Jan;84(1):87-136
pubmed: 14715912
Neuroscience. 2000;98(1):9-22
pubmed: 10858607
J Neuroinflammation. 2011 Oct 19;8:143
pubmed: 22011386
PLoS One. 2013;8(2):e54527
pubmed: 23408944
Aging Ment Health. 2020 May;24(5):705-708
pubmed: 30691295

Auteurs

Paul F Smith (PF)

Department of Pharmacology and Toxicology, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, Dunedin, New Zealand.
Brain Research New Zealand, The Eisdell Moore Centre for Hearing and Balance Research, University of Auckland, Auckland, >New Zealand.

Bruno Truchet (B)

Aix Marseille University, CNRS, LNC UMR 7291, FR 3C FR 3512, Marseille, France.

Franck A Chaillan (FA)

Aix Marseille University, CNRS, LNC UMR 7291, FR 3C FR 3512, Marseille, France.

Yiwen Zheng (Y)

Department of Pharmacology and Toxicology, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, Dunedin, New Zealand.
Brain Research New Zealand, The Eisdell Moore Centre for Hearing and Balance Research, University of Auckland, Auckland, >New Zealand.

Stephane Besnard (S)

Université de Normandie, INSERM U 1075 COMETE, Caen, France.

Classifications MeSH